Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

By Pearlman David   Peden David   Condemi John   Weinstein Steven   White Martha   Baitinger Leslie   Scott Catherine   Ho Shu   House Karen   Dorinsky Paul  

Journal of Asthma, Vol. 41, Iss. 8, 2004-01 ,pp. : 797-806

Informa Healthcare

Access to resources Recommend Favorite

An Electronic Diary Is Shown to Be More Reliable than a Paper Diary: Results from a Randomized Crossover Study in Patients with Persistent Asthma

By Ireland Andrea M.   Wiklund Ingela   Hsieh Ray   Dale Peter   O'Rourke Erin  

Journal of Asthma, Vol. 49, Iss. 9, 2012-11 ,pp. : 952-960

Informa Healthcare

Access to resources Recommend Favorite

Fluticasone Propionate HFA-134a Pressurized Metered-Dose Inhaler in Adolescents and Adults with Moderate to Severe Asthma

By Pinnas Jacob   Noonan Michael   Weinstein Steven   Chervinsky Paul   Scott Catherine   Herje Nancy   Wu Wei   Crim Courtney  

Journal of Asthma, Vol. 42, Iss. 10, 2005-12 ,pp. : 865-871

Informa Healthcare

Access to resources Recommend Favorite

Usefulness of QVARTM for the Treatment of Bronchial Asthma—With and Without Use of an Inhalation Device

By Tohda Yuji   Tsuji Fumio   Kubo Hirokazu   Haraguchi Ryuta   Iwanaga Takashi  

Journal of Asthma, Vol. 43, Iss. 8, 2006-09 ,pp. : 613-618

Informa Healthcare

Access to resources Recommend Favorite

Soluble CTLA-4 in Sera of Patients with Bronchial Asthma

By Shi Huan-Zhong   Mo Xiao-Yun   Zhong Xiao-Ning  

Journal of Asthma, Vol. 42, Iss. 2, 2004-03 ,pp. : 133-139

Informa Healthcare

Access to resources Recommend Favorite